Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies

Alison M. Emslie-Smith, Kiichi Arahata, Andrew G Engel

Research output: Contribution to journalArticle

294 Citations (Scopus)

Abstract

Major histocompatibility complex class I (MHC-I) expression on target cells is a prerequisite for antigen-specific T cell-mediated cytotoxicity (TCMC). Enhanced MHC-I expression has been attributed to interferons (IFNs) released from inflammatory cells. In previous studies, we found evidence of TCMC (invasion of non-necrotic muscle fibers by cytotoxic T cells) in polymyositis (PM) and in inclusion body myositis (IBM). We occasionally found evidence of TCMC in Duchenne dystrophy (DD) but not in dermatomyositis (DM). This study examines the relationships between TCMC, MHC-I expression, and IFN immunoreactivity in these diseases and normal controls. In controls, reactivity for MHC-I was confined to blood vessels. In all diseases, regenerating fibers expressed MHC-I. In IBM, PM and DD, all nonnecrotic muscle fibers invaded by CD8+ cells and some adjacent fibers expressed MHC-I. In DM, myrial muscle fibers expressed MHC-I, but none were invadedy by CD8+ cells. In all disease, only a few mononuclear cells and no muscle fiber surfaces were immunoreactive for IFNs. We conclude that MHC-I expression on muscle fibers is necessary but not sufficient for TCMC in myopathy; that the biological significance of increased MHC-I expression in DM remains undefined; and that currently available and appropriately controlled immunocytochemical methods show no relationship between increased MHC-I expression on muscle fibers and local IFN synthesis by mononuclear cells.

Original languageEnglish (US)
Pages (from-to)224-231
Number of pages8
JournalHuman Pathology
Volume20
Issue number3
DOIs
StatePublished - 1989

Fingerprint

Histocompatibility Antigens Class I
Muscular Diseases
Major Histocompatibility Complex
Interferons
T-Lymphocytes
Dermatomyositis
Muscles
Inclusion Body Myositis
Polymyositis
Muscle Cells
Blood Vessels
Antigens

Keywords

  • cell-mediated cytotoxicity
  • interferons
  • MHC class I antigen
  • myopathies

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. / Emslie-Smith, Alison M.; Arahata, Kiichi; Engel, Andrew G.

In: Human Pathology, Vol. 20, No. 3, 1989, p. 224-231.

Research output: Contribution to journalArticle

@article{8237353ffcf74594bcac445e848b30b5,
title = "Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies",
abstract = "Major histocompatibility complex class I (MHC-I) expression on target cells is a prerequisite for antigen-specific T cell-mediated cytotoxicity (TCMC). Enhanced MHC-I expression has been attributed to interferons (IFNs) released from inflammatory cells. In previous studies, we found evidence of TCMC (invasion of non-necrotic muscle fibers by cytotoxic T cells) in polymyositis (PM) and in inclusion body myositis (IBM). We occasionally found evidence of TCMC in Duchenne dystrophy (DD) but not in dermatomyositis (DM). This study examines the relationships between TCMC, MHC-I expression, and IFN immunoreactivity in these diseases and normal controls. In controls, reactivity for MHC-I was confined to blood vessels. In all diseases, regenerating fibers expressed MHC-I. In IBM, PM and DD, all nonnecrotic muscle fibers invaded by CD8+ cells and some adjacent fibers expressed MHC-I. In DM, myrial muscle fibers expressed MHC-I, but none were invadedy by CD8+ cells. In all disease, only a few mononuclear cells and no muscle fiber surfaces were immunoreactive for IFNs. We conclude that MHC-I expression on muscle fibers is necessary but not sufficient for TCMC in myopathy; that the biological significance of increased MHC-I expression in DM remains undefined; and that currently available and appropriately controlled immunocytochemical methods show no relationship between increased MHC-I expression on muscle fibers and local IFN synthesis by mononuclear cells.",
keywords = "cell-mediated cytotoxicity, interferons, MHC class I antigen, myopathies",
author = "Emslie-Smith, {Alison M.} and Kiichi Arahata and Engel, {Andrew G}",
year = "1989",
doi = "10.1016/0046-8177(89)90128-7",
language = "English (US)",
volume = "20",
pages = "224--231",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies

AU - Emslie-Smith, Alison M.

AU - Arahata, Kiichi

AU - Engel, Andrew G

PY - 1989

Y1 - 1989

N2 - Major histocompatibility complex class I (MHC-I) expression on target cells is a prerequisite for antigen-specific T cell-mediated cytotoxicity (TCMC). Enhanced MHC-I expression has been attributed to interferons (IFNs) released from inflammatory cells. In previous studies, we found evidence of TCMC (invasion of non-necrotic muscle fibers by cytotoxic T cells) in polymyositis (PM) and in inclusion body myositis (IBM). We occasionally found evidence of TCMC in Duchenne dystrophy (DD) but not in dermatomyositis (DM). This study examines the relationships between TCMC, MHC-I expression, and IFN immunoreactivity in these diseases and normal controls. In controls, reactivity for MHC-I was confined to blood vessels. In all diseases, regenerating fibers expressed MHC-I. In IBM, PM and DD, all nonnecrotic muscle fibers invaded by CD8+ cells and some adjacent fibers expressed MHC-I. In DM, myrial muscle fibers expressed MHC-I, but none were invadedy by CD8+ cells. In all disease, only a few mononuclear cells and no muscle fiber surfaces were immunoreactive for IFNs. We conclude that MHC-I expression on muscle fibers is necessary but not sufficient for TCMC in myopathy; that the biological significance of increased MHC-I expression in DM remains undefined; and that currently available and appropriately controlled immunocytochemical methods show no relationship between increased MHC-I expression on muscle fibers and local IFN synthesis by mononuclear cells.

AB - Major histocompatibility complex class I (MHC-I) expression on target cells is a prerequisite for antigen-specific T cell-mediated cytotoxicity (TCMC). Enhanced MHC-I expression has been attributed to interferons (IFNs) released from inflammatory cells. In previous studies, we found evidence of TCMC (invasion of non-necrotic muscle fibers by cytotoxic T cells) in polymyositis (PM) and in inclusion body myositis (IBM). We occasionally found evidence of TCMC in Duchenne dystrophy (DD) but not in dermatomyositis (DM). This study examines the relationships between TCMC, MHC-I expression, and IFN immunoreactivity in these diseases and normal controls. In controls, reactivity for MHC-I was confined to blood vessels. In all diseases, regenerating fibers expressed MHC-I. In IBM, PM and DD, all nonnecrotic muscle fibers invaded by CD8+ cells and some adjacent fibers expressed MHC-I. In DM, myrial muscle fibers expressed MHC-I, but none were invadedy by CD8+ cells. In all disease, only a few mononuclear cells and no muscle fiber surfaces were immunoreactive for IFNs. We conclude that MHC-I expression on muscle fibers is necessary but not sufficient for TCMC in myopathy; that the biological significance of increased MHC-I expression in DM remains undefined; and that currently available and appropriately controlled immunocytochemical methods show no relationship between increased MHC-I expression on muscle fibers and local IFN synthesis by mononuclear cells.

KW - cell-mediated cytotoxicity

KW - interferons

KW - MHC class I antigen

KW - myopathies

UR - http://www.scopus.com/inward/record.url?scp=0024604938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024604938&partnerID=8YFLogxK

U2 - 10.1016/0046-8177(89)90128-7

DO - 10.1016/0046-8177(89)90128-7

M3 - Article

C2 - 2470663

AN - SCOPUS:0024604938

VL - 20

SP - 224

EP - 231

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 3

ER -